2018•European Journal of Hospital PharmacyOpen access

High-dose quetiapine and therapeutic monitoring

Hervé Javelot, Francis Rangoni, Luisa Weiner, Bruno Michel

Abstract

Quetiapine is an atypical antipsychotic with a good safety profile permitting its administration beyond the maximum dose of 800 mg/day. We report the case of a patient with a resistant schizophrenia treated with high doses of quetiapine (up to 2000 mg/day) combined with drug monitoring and with favourable therapeutic response and tolerance.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Quetiapine, Quetiapine Fumarate, Atypical antipsychotic, Medicine, Therapeutic drug monitoring, Antipsychotic drug, Antipsychotic, Drug